CARMEL-HAIFA UNIVERSITY ECONOMIC CORP., LTD.
|CARMEL-HAIFA UNIVERSITY ECONOMIC CORP., LTD. Patent applications|
|Patent application number||Title||Published|
|20140248371||SPALAX FIBROBLAST-DERIVED ANTI-CANCER AGENTS - A conditioned cell culture medium of cells derived from||09-04-2014|
|20140234826||SYSTEM AND METHOD FOR EVALUATING AND TRAINING ACADEMIC SKILLS - System and method for improving reading speed and comprehension of a user that use a special software application operable through a computer processor. The method and system are configured for receiving personal details and reading level of the user; setting initial presentation pace and acceleration rate; presenting textual content over a computer screen, selected according to the received reading level and personal details; determining a current presentation pace according to the initial presentation pace and acceleration rate at each given timeframe; and manipulating presentation of text parts of the presented textual content at each given timeframe, according to the current presentation pace. The manipulation is done by erasing or blurring these text parts at a rate that corresponds to the current presentation pace.||08-21-2014|
|20130236447||COGNITIVE FUNCTION - Inhibition of eIF-2α phosphorylation can be used to improve cognitive function and/or to treat dementia, including Alzheimer's Disease. In particular, this can be achieved by inhibiting the kinase activity of PKR in a non-toxic manner.||09-12-2013|
|20110257988||MULTI-PHASE ANCHOR-BASED DIAGNOSTIC DECISION-SUPPORT METHOD AND SYSTEM - A medical diagnosis decision support system for assisting a health professional to diagnose a medical condition. The system is first provided with an anchor condition that can be a symptom, a sign, a laboratory test result, or an imaging test results or any combination thereof The system then guides users in a series of predetermined phases regarding abstract or concrete diagnosis groups that should be considered and appropriate data that should be collected during the clinical investigation process. The system suggests history and physical examination clinical data items, laboratory, and imaging tests that should be collected in order to differentiate among alternative diagnoses. In each phase, possible diagnoses are listed and ranked.||10-20-2011|
|20110052566||COGNITIVE FUNCTION - Inhibition of eIF-2α phosphorylation can be used to improve cognitive function and/or to treat dementia, including Alzheimer's Disease. In particular, this can be achieved by inhibiting the kinase activity of PKR in a non-toxic manner.||03-03-2011|
Patent applications by CARMEL-HAIFA UNIVERSITY ECONOMIC CORP., LTD.